港股异动 | 艾迪康控股(09860)收涨逾9% 高盛称诊断行业开始显现复苏迹象公司业绩表现好于ICL同行

智通财经网2025-11-03

智通财经APP获悉，艾迪康控股(09860)盘中放量涨超13%，截至收盘，涨9.27%，报6.6港元，成交额4153.11万港元。消息面上，高盛发布的最新研报显示，该行认为中国诊断行业，包括独立临床实验室(ICL)和体外诊断(IVD)公司，在2025年第三季度开始显现复苏迹象。在ICL板块，金域医学和迪安诊断均报告运营现金流改善，同时营收环比增长，利润率也扩大，尽管两家公司均未达到营收目标。该行...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2580260788?lang=zh_CN&edition=full","thumbnail":"https://img.zhitongcaijing.com/image/20251103/20251103163436_82612.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","is_english":false,"pubTime":"2025-11-03 16:33","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2580260788","market":"fut","top_or_hot":-1,"title":"港股异动 | 艾迪康控股(09860)收涨逾9% 高盛称诊断行业开始显现复苏迹象 公司业绩表现好于ICL同行","media":"智通财经网","content":"<div>\n<p>智通财经APP获悉，艾迪康控股(09860)盘中放量涨超13%，截至收盘，涨9.27%，报6.6港元，成交额4153.11万港元。消息面上，高盛发布的最新研报显示，该行认为中国诊断行业，包括独立临床实验室(ICL)和体外诊断(IVD)公司，在2025年第三季度开始显现复苏迹象。在ICL板块，金域医学和迪安诊断均报告运营现金流改善，同时营收环比增长，利润率也扩大，尽管两家公司均未达到营收目标。该行...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1364454.html\">网页链接</a>\n\n</div>\n","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 艾迪康控股(09860)收涨逾9% 高盛称诊断行业开始显现复苏迹象 公司业绩表现好于ICL同行</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 艾迪康控股(09860)收涨逾9% 高盛称诊断行业开始显现复苏迹象 公司业绩表现好于ICL同行\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-03 16:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1364454.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，艾迪康控股(09860)盘中放量涨超13%，截至收盘，涨9.27%，报6.6港元，成交额4153.11万港元。消息面上，高盛发布的最新研报显示，该行认为中国诊断行业，包括独立临床实验室(ICL)和体外诊断(IVD)公司，在2025年第三季度开始显现复苏迹象。在ICL板块，金域医学和迪安诊断均报告运营现金流改善，同时营收环比增长，利润率也扩大，尽管两家公司均未达到营收目标。该行...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1364454.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1668664300.SGD","symbol_name":"Blackrock World Financials A2 SGD-H","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1364454.html","article_id":"2580260788","we_media_id":null,"thumbnails":["https://img.zhitongcaijing.com/image/20251103/20251103163436_82612.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2580260788","pubTimestamp":1762158830,"columns":[],"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"艾迪康控股(09860)盘中放量涨超13%，截至收盘，涨9.27%，报6.6港元，成交额4153.11万港元。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU2471134879.HKD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (HKD) INC","BK4550":"红杉资本持仓","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","BK4552":"Archegos爆仓风波概念","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LU2471134523.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) ACC","BK1219":"保健护理服务","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU2471134796.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) INC","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK4588":"碎股","ICL":"以色列化学","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU2750360641.GBP":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (GBPHDG) INC","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2750360997.AUD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (AUDHDG) INC","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","BK4093":"化肥与农用药剂","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","LU0251142724.SGD":"Fidelity America A-SGD","09860":"艾迪康控股","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","BK4127":"投资银行业与经纪业","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","IE0004086264.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"A\" (USD) ACC","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","BK4516":"特朗普概念","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","BK4504":"桥水持仓","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","LU0106831901.USD":"贝莱德世界金融基金A2"},"translate_title":"Changes in Hong Kong stocks | Adikon Holdings (09860) closed up more than 9% Goldman Sachs said the diagnostics industry began to show signs of recovery, and the company's performance outperformed its ICL peers","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICL":1.5,"09860":1.5},"content_text":"智通财经APP获悉，艾迪康控股(09860)盘中放量涨超13%，截至收盘，涨9.27%，报6.6港元，成交额4153.11万港元。消息面上，高盛发布的最新研报显示，该行认为中国诊断行业，包括独立临床实验室(ICL)和体外诊断(IVD)公司，在2025年第三季度开始显现复苏迹象。在ICL板块，金域医学和迪安诊断均报告运营现金流改善，同时营收环比增长，利润率也扩大，尽管两家公司均未达到营收目标。该行认为这些趋势表明，行业整合已经开始。中信建投也在研报中指出，ICL板块25第三季度收入降幅有所缩窄，利润端仍受减值影响。该行指出，ICL行业增速存在不确定性，但是成本和质量控制较好的企业有望实现份额提升。据悉，从上半年业绩来看，艾迪康的毛利达到了4.5亿，净利润4300万，是三家头部ICL企业里面净利润最好的，迪安诊断期内扭亏为盈，实现了1027万的净利润；金域仍处于亏损状态。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2580260788","isCrawlerRequest":true}

港股异动 | 艾迪康控股(09860)收涨逾9% 高盛称诊断行业开始显现复苏迹象 公司业绩表现好于ICL同行

精彩评论

港股异动 | 艾迪康控股(09860)收涨逾9% 高盛称诊断行业开始显现复苏迹象公司业绩表现好于ICL同行